$NTIC
NORTHERN TECHNOLOGIES INTERNATIONAL CORP

2015 Q4 Form 10-Q Financial Statement

#000117184316007133 Filed on January 11, 2016

View on sec.gov

Income Statement

Concept 2015 Q4 2014 Q4
Revenue $7.024M $7.214M
YoY Change -2.63% 14.34%
Cost Of Revenue $4.875M $4.807M
YoY Change 1.43% 15.54%
Gross Profit $2.149M $2.407M
YoY Change -10.74% 11.92%
Gross Profit Margin 30.59% 33.37%
Selling, General & Admin $3.700M $2.933M
YoY Change 26.13% 8.23%
% of Gross Profit 172.16% 121.83%
Research & Development $1.004M $1.050M
YoY Change -4.36% -7.9%
% of Gross Profit 46.72% 43.61%
Depreciation & Amortization $159.0K $117.7K
YoY Change 35.14% -15.94%
% of Gross Profit 7.4% 4.89%
Operating Expenses $4.704M $4.510M
YoY Change 4.29% 118.94%
Operating Profit -$85.59K $1.638M
YoY Change -105.23% 1698.26%
Interest Expense $4.726K $5.005K
YoY Change -5.57% -99.65%
% of Operating Profit 0.31%
Other Income/Expense, Net
YoY Change
Pretax Income -$80.00K $1.650M
YoY Change -104.85% 10.0%
Income Tax -$3.502K $183.7K
% Of Pretax Income 11.13%
Net Earnings -$234.4K $1.008M
YoY Change -123.24% 17.43%
Net Earnings / Revenue -3.34% 13.98%
Basic Earnings Per Share -$0.05 $0.22
Diluted Earnings Per Share -$0.05 $0.22
COMMON SHARES
Basic Shares Outstanding 4.538M 4.519M
Diluted Shares Outstanding 4.538M 4.660M

Balance Sheet

Concept 2015 Q4 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.600M $6.620M
YoY Change -45.62% 69.31%
Cash & Equivalents $3.072M $2.599M
Short-Term Investments $530.0K $4.020M
Other Short-Term Assets $990.0K $1.550M
YoY Change -36.13% 51.96%
Inventory $7.629M $5.640M
Prepaid Expenses $573.0K
Receivables $4.240M $3.900M
Other Receivables $1.820M $2.910M
Total Short-Term Assets $18.28M $20.62M
YoY Change -11.33% 16.89%
LONG-TERM ASSETS
Property, Plant & Equipment $7.394M $6.800M
YoY Change 8.74% 26.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $20.37M $23.30M
YoY Change -12.58% -12.5%
Other Assets $240.9K $1.090M
YoY Change -77.9% 5.83%
Total Long-Term Assets $24.91M $32.43M
YoY Change -23.17% -5.01%
TOTAL ASSETS
Total Short-Term Assets $18.28M $20.62M
Total Long-Term Assets $24.91M $32.43M
Total Assets $50.59M $53.05M
YoY Change -4.63% 2.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.325M $2.140M
YoY Change 8.63% -10.08%
Accrued Expenses $1.200M $1.140M
YoY Change 5.26% -32.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.528M $3.560M
YoY Change -0.91% -19.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.528M $3.560M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.710M $7.220M
YoY Change -7.06% -24.16%
SHAREHOLDERS EQUITY
Retained Earnings $34.29M
YoY Change
Common Stock $13.64M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.88M $45.82M
YoY Change
Total Liabilities & Shareholders Equity $50.59M $53.05M
YoY Change -4.63% 2.45%

Cashflow Statement

Concept 2015 Q4 2014 Q4
OPERATING ACTIVITIES
Net Income -$234.4K $1.008M
YoY Change -123.24% 17.43%
Depreciation, Depletion And Amortization $159.0K $117.7K
YoY Change 35.14% -15.94%
Cash From Operating Activities -$750.0K -$380.0K
YoY Change 97.37% 80.95%
INVESTING ACTIVITIES
Capital Expenditures $264.2K $470.7K
YoY Change -43.87% -313.96%
Acquisitions
YoY Change
Other Investing Activities $1.500M $1.500M
YoY Change 0.0% 14900.0%
Cash From Investing Activities $1.220M $970.0K
YoY Change 25.77% -561.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $47.67K $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K -440.0K
YoY Change -97.73% -4500.0%
NET CHANGE
Cash From Operating Activities -750.0K -380.0K
Cash From Investing Activities 1.220M 970.0K
Cash From Financing Activities -10.00K -440.0K
Net Change In Cash 460.0K 150.0K
YoY Change 206.67% -136.59%
FREE CASH FLOW
Cash From Operating Activities -$750.0K -$380.0K
Capital Expenditures $264.2K $470.7K
Free Cash Flow -$1.014M -$850.7K
YoY Change 19.22% -8607.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
46892
CY2014Q4 ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
156332
CY2015Q4 ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
-363381
CY2015Q4 ntic Allocated Share Based Compensation Expense Estimate Next Fiscal Year
AllocatedShareBasedCompensationExpenseEstimateNextFiscalYear
159600
CY2015Q4 ntic Allocated Share Based Compensation Expense Estimate Remainder Of Fiscal Year
AllocatedShareBasedCompensationExpenseEstimateRemainderOfFiscalYear
305584
CY2015Q4 ntic Cost Of Goods Sold As Percentage Of Product Sales
CostOfGoodsSoldAsPercentageOfProductSales
CY2014Q4 ntic Cost Of Goods Sold As Percentage Of Product Sales
CostOfGoodsSoldAsPercentageOfProductSales
CY2015Q4 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
CY2014Q4 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
CY2015Q4 ntic Entity Wide Trade Joint Venture Receivables Four Joint Venturespercentage
EntityWideTradeJointVentureReceivablesFourJointVenturespercentage
0.644
CY2015Q3 ntic Entity Wide Trade Joint Venture Receivables Four Joint Venturespercentage
EntityWideTradeJointVentureReceivablesFourJointVenturespercentage
0.67
CY2015Q4 ntic Estimated Forfeiture Rate For Stock Options
EstimatedForfeitureRateForStockOptions
0.1
CY2015Q4 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
1485429
CY2014Q4 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
2133670
CY2015Q4 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1496054
CY2015Q3 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1449162
CY2015Q4 ntic Allocated Share Based Compensation Expense Estimate Fiscal Year Two
AllocatedShareBasedCompensationExpenseEstimateFiscalYearTwo
79800
CY2014Q4 ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
-163824
CY2015Q4 ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
-45761
CY2014Q4 ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
-398572
CY2015Q4 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
6501410
CY2014Q4 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
6480991
CY2015Q4 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
523027
CY2014Q4 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
733104
CY2015Q4 ntic Number Of Joint Ventures Accounted For Certain Percentage Of Companys Trade Joint Venture Receivables
NumberOfJointVenturesAccountedForCertainPercentageOfCompanysTradeJointVentureReceivables
4
CY2015Q4 ntic Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
2
CY2015Q4 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
1485429
CY2014Q4 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
2133670
CY2015Q4 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
3637387
CY2015Q4 us-gaap Cost Method Investments
CostMethodInvestments
1883668
CY2015Q3 us-gaap Cost Method Investments
CostMethodInvestments
1883668
CY2015Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4875423
CY2014Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4806611
CY2015Q3 us-gaap Assets Current
AssetsCurrent
19275612
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
40844930
CY2015Q3 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
4027167
CY2015Q4 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
599616
CY2015Q3 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
645377
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2324787
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2101175
CY2015Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
0
CY2014Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
240000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3445567
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3287910
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4049004
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3180811
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13550424
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13441264
CY2015Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
29758
CY2014Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
21916
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40000
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40000
CY2015Q4 us-gaap Assets
Assets
50592691
CY2015Q3 us-gaap Assets
Assets
51565648
CY2015Q4 us-gaap Assets Current
AssetsCurrent
18283636
CY2015Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
24914571
CY2015Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
24996873
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
528867
CY2015Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2027441
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
528867
CY2015Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2027441
CY2015Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6384512
CY2015Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6180089
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2623981
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2477017
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3072015
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2598739
CY2015Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
448034
CY2014Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
121722
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4538317
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4539045
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4538317
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4539045
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
90766
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
90781
CY2015Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1102545
CY2014Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-196811
CY2015Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
164775
CY2014Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
384691
CY2015Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-937770
CY2014Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
187880
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
39350417
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
9648081
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
14035784
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
1961922
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
3184570
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
89930
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
1215139
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
21871209
CY2015Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
424108
CY2015Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
424108
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1175928
CY2015Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1176012
CY2015Q4 us-gaap Depreciation
Depreciation
159048
CY2014Q4 us-gaap Depreciation
Depreciation
117690
CY2015Q4 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">2. <div style="display: inline; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;Recently Issued Accounting PronouncementS</div></div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">In May 2014, the Financial Accounting Standards Board (FASB) issued <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers, Topic 606</div> (Accounting Standards Update (ASU) No. 2014-09), which provides a framework for the recognition of revenue, with the objective that recognized revenues properly reflect amounts an entity is entitled to receive in exchange for goods and services. This guidance, which includes additional disclosure requirements regarding revenue, cash flows and obligations related to contracts with customers, was originally to be effective for the Company beginning in fiscal year 2018. In July 2015, the FASB confirmed a one year deferral of the effective date of the new revenue standard which also allows early adoption as of the original effective date. The updated guidance will be effective for the Company&#x2019;s first quarter of 2019. The Company is currently evaluating the impact of adopting ASU 2014-09 on its consolidated financial statements, but believes there will be no material impact, if any.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">In July 2015, the FASB issued ASU No. 2015-11, &#x201c;<div style="display: inline; font-style: italic;">Inventory</div>&#x201d;, which modifies the subsequent measurement of inventories recorded under a first-in-first-out or average cost method. Under the new standard, such inventories are required to be measured at the lower of cost and net realizable value. The new standard is effective for the Company&#x2019;s fiscal year 2018, with prospective application. The Company does not expect the adoption of the provisions of ASU 2015-11 to have a material impact on its consolidated financial statements.</div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on the Company&#x2019;s consolidated financial position or operating results.</div></div>
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2014Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2014Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2015Q4 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-10799
CY2014Q4 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-28286
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
768783
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1056257
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
53883178
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
52853938
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
50371596
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
49295116
CY2015Q4 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
12948319
CY2015Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
12288383
CY2014Q4 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
29120852
CY2015Q4 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
20369002
CY2015Q3 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
20544238
CY2015Q4 us-gaap Equity Method Investments
EquityMethodInvestments
20369002
CY2015Q3 us-gaap Equity Method Investments
EquityMethodInvestments
20544238
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1245060
CY2015Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1262219
CY2015Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
CY2014Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-12561
CY2015Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1857613
CY2014Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1538262
CY2015Q4 us-gaap Gross Profit
GrossProfit
2149014
CY2014Q4 us-gaap Gross Profit
GrossProfit
2407484
CY2015Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
983753
CY2014Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1606683
CY2015Q4 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-76144
CY2014Q4 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
1647780
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3502
CY2014Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
183684
CY2015Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
323817
CY2015Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
198462
CY2015Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
258792
CY2014Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-18080
CY2015Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1783
CY2014Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
10821
CY2015Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-480440
CY2014Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-804762
CY2015Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
133668
CY2014Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
154937
CY2015Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
180185
CY2014Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-276298
CY2015Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
153831
CY2014Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
338643
CY2015Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2014Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
140648
CY2015Q4 us-gaap Interest Expense
InterestExpense
4726
CY2014Q4 us-gaap Interest Expense
InterestExpense
5005
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6188971
CY2015Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6023427
CY2015Q4 us-gaap Inventory Gross
InventoryGross
7628754
CY2015Q3 us-gaap Inventory Gross
InventoryGross
7468441
CY2015Q4 us-gaap Inventory Net
InventoryNet
7628754
CY2015Q3 us-gaap Inventory Net
InventoryNet
7468441
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1439783
CY2015Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1445014
CY2015Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
14173
CY2014Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
15127
CY2015Q4 us-gaap Land
Land
310365
CY2015Q3 us-gaap Land
Land
310365
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50592691
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51565648
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3527508
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3671841
CY2015Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4145174
CY2015Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4090619
CY2015Q4 us-gaap Minority Interest
MinorityInterest
3184477
CY2015Q3 us-gaap Minority Interest
MinorityInterest
3019702
CY2015Q4 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-12706
CY2014Q4 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-437930
CY2015Q4 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1221787
CY2014Q4 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
972059
CY2015Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-750248
CY2014Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-384121
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-234351
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
1008265
CY2015Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
161709
CY2014Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
455831
CY2015Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
4703787
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
130736
CY2015Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-865128
CY2014Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1276216
CY2015Q4 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
316994
CY2014Q4 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
527117
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
4510179
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-85591
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1637658
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
433938
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
514409
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
240913
CY2015Q4 us-gaap Other Operating Income
OtherOperatingIncome
2469182
CY2014Q4 us-gaap Other Operating Income
OtherOperatingIncome
3740353
CY2015Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
47669
CY2014Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2015Q4 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
CY2014Q4 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
560000
CY2015Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12599
CY2014Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
52397
CY2014Q4 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0
CY2015Q4 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0
CY2015Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
264188
CY2014Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
470711
CY2015Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2015Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
573018
CY2015Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
411473
CY2015Q4 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
320786
CY2014Q4 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
85641
CY2015Q4 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
1498574
CY2014Q4 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
1495167
CY2015Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2014Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
99450
CY2015Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
34963
CY2014Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
22620
CY2015Q4 us-gaap Profit Loss
ProfitLoss
-72642
CY2014Q4 us-gaap Profit Loss
ProfitLoss
1464096
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
34522871
CY2015Q4 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
18308141
CY2015Q3 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
18483377
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10840051
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10581073
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7394484
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7293163
CY2015Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1004097
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1049913
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3072015
CY2015Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2623981
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
34288520
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
7024437
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
7214095
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y354D
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y273D
CY2015Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2015Q4 us-gaap Selling Expense
SellingExpense
1525083
CY2014Q4 us-gaap Selling Expense
SellingExpense
1394887
CY2015Q4 us-gaap Share Based Compensation
ShareBasedCompensation
121854
CY2014Q4 us-gaap Share Based Compensation
ShareBasedCompensation
143897
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.46
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.466
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0163
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0163
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
53447
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
45067
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.48
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.58
CY2014Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.65
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2014Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
18000
CY2015Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
3166
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
43880706
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
44874105
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47065183
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47893807
CY2015Q4 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
15.07
CY2015Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4538371
CY2014Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4659621
CY2015Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4538371
CY2014Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4518973

Files In Submission

Name View Source Status
0001171843-16-007133-index-headers.html Edgar Link pending
0001171843-16-007133-index.html Edgar Link pending
0001171843-16-007133.txt Edgar Link pending
0001171843-16-007133-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gff10q_011116p.htm Edgar Link pending
lynch_sig.jpg Edgar Link pending
ntic-20151130.xml Edgar Link completed
ntic-20151130.xsd Edgar Link pending
ntic-20151130_cal.xml Edgar Link unprocessable
ntic-20151130_def.xml Edgar Link unprocessable
ntic-20151130_lab.xml Edgar Link unprocessable
ntic-20151130_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wolsfeld_sig.jpg Edgar Link pending